Guangzhou Wondfo BiotechLtd Dividends and Buybacks
Dividend criteria checks 2/6
Guangzhou Wondfo BiotechLtd is a dividend paying company with a current yield of 1.65% that is well covered by earnings.
Key information
1.6%
Dividend yield
-7.2%
Buyback Yield
Total Shareholder Yield | -5.5% |
Future Dividend Yield | 1.6% |
Dividend Growth | 18.0% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | CN¥0.400 |
Payout ratio | 35% |
Recent dividend and buyback updates
Recent updates
Returns On Capital At Guangzhou Wondfo BiotechLtd (SZSE:300482) Paint A Concerning Picture
Nov 18Guangzhou Wondfo BiotechLtd's (SZSE:300482) Shareholders May Want To Dig Deeper Than Statutory Profit
Nov 01Cautious Investors Not Rewarding Guangzhou Wondfo Biotech Co.,Ltd's (SZSE:300482) Performance Completely
Sep 06Returns On Capital At Guangzhou Wondfo BiotechLtd (SZSE:300482) Paint A Concerning Picture
Jul 27Guangzhou Wondfo BiotechLtd's (SZSE:300482) Solid Earnings May Rest On Weak Foundations
Apr 29A Piece Of The Puzzle Missing From Guangzhou Wondfo Biotech Co.,Ltd's (SZSE:300482) Share Price
Mar 27There Are Reasons To Feel Uneasy About Guangzhou Wondfo BiotechLtd's (SZSE:300482) Returns On Capital
Feb 29Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 300482 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 300482's dividend payments have increased, but the company has only paid a dividend for 9 years.
Dividend Yield vs Market
Guangzhou Wondfo BiotechLtd Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (300482) | 1.6% |
Market Bottom 25% (CN) | 0.6% |
Market Top 25% (CN) | 2.2% |
Industry Average (Medical Equipment) | 1.7% |
Analyst forecast (300482) (up to 3 years) | 1.6% |
Notable Dividend: 300482's dividend (1.65%) is higher than the bottom 25% of dividend payers in the CN market (0.53%).
High Dividend: 300482's dividend (1.65%) is low compared to the top 25% of dividend payers in the CN market (2.08%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (35.3%), 300482's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (178.4%), 300482's dividend payments are not well covered by cash flows.